Brookfield and Caisse de dépôt et placement du Québec (CDPQ) are reportedly finalizing an acquisition of life sciences diagnostics company Antylia Scientific from private equity firm GTCR LLC in a deal valued around $1.4 billion. The potential transaction highlights continued private equity interest in the healthcare and diagnostics space. Dinesh Nair | Bloomberg https://lnkd.in/emfcYXXg #LBO #Buyouts
